244 related articles for article (PubMed ID: 25495924)
1. MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis.
D'Angelo E; Vicentini C; Agostini M; Kiss A; Baffa R; Scarpa A; Fassan M
Curr Drug Targets; 2015; 16(4):383-92. PubMed ID: 25495924
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
[TBL] [Abstract][Full Text] [Related]
3. Implications of microRNA dysregulation in the development of prostate cancer.
Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
[TBL] [Abstract][Full Text] [Related]
4. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
5. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
Neelakandan K; Babu P; Nair S
Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
[TBL] [Abstract][Full Text] [Related]
7. Biological implications and clinical value of mir-210 in gastrointestinal cancer.
Yang W; Ma J; Zhou W; Zhou X; Cao B; Fan D; Hong L
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):539-548. PubMed ID: 28317401
[TBL] [Abstract][Full Text] [Related]
8. The role of microRNAs in human breast cancer progression.
Zhang W; Liu J; Wang G
Tumour Biol; 2014 Jul; 35(7):6235-44. PubMed ID: 24938874
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Asiaf A; Ahmad ST; Arjumand W; Zargar MA
Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.
Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S
Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018
[TBL] [Abstract][Full Text] [Related]
15. Distinct methylation levels of mature microRNAs in gastrointestinal cancers.
Konno M; Koseki J; Asai A; Yamagata A; Shimamura T; Motooka D; Okuzaki D; Kawamoto K; Mizushima T; Eguchi H; Takiguchi S; Satoh T; Mimori K; Ochiya T; Doki Y; Ofusa K; Mori M; Ishii H
Nat Commun; 2019 Aug; 10(1):3888. PubMed ID: 31467274
[TBL] [Abstract][Full Text] [Related]
16. Recent trends in targeting miRNAs for cancer therapy.
Shah V; Shah J
J Pharm Pharmacol; 2020 Dec; 72(12):1732-1749. PubMed ID: 32783235
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers.
Pourhanifeh MH; Vosough M; Mahjoubin-Tehran M; Hashemipour M; Nejati M; Abbasi-Kolli M; Sahebkar A; Mirzaei H
Pharmacol Res; 2020 Nov; 161():105133. PubMed ID: 32822869
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs: molecular microsensors in gastrointestinal cancer.
Blanco-Calvo M; Calvo L; Figueroa A; Haz-Conde M; Antón-Aparicio L; Valladares-Ayerbes M
Sensors (Basel); 2012; 12(7):9349-62. PubMed ID: 23012546
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
Gordanpour A; Nam RK; Sugar L; Seth A
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
[TBL] [Abstract][Full Text] [Related]
20. The clinical potential of adipogenesis and obesity-related microRNAs.
Zaiou M; El Amri H; Bakillah A
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):91-111. PubMed ID: 29170059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
